135 related articles for article (PubMed ID: 31421153)
1. Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating FoxO3a.
Sun Z; Li M; Bai L; Fu J; Lu J; Wu M; Zhou C; Zhang Y; Wu Y
Toxicol Lett; 2019 Oct; 315():1-8. PubMed ID: 31421153
[TBL] [Abstract][Full Text] [Related]
2. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells.
Zhang L; Liu L; Zhan S; Chen L; Wang Y; Zhang Y; Du J; Wu Y; Gu L
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477221
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic effect of arsenic trioxide in HUVECs by FoxO3a-regulated autophagy.
Sun Z; Cao Y; Xing Y; Wu M; Shao X; Huang Q; Bai L; Wang L; Zhao Y; Wu Y
J Biochem Mol Toxicol; 2021 May; 35(5):e22728. PubMed ID: 33592126
[TBL] [Abstract][Full Text] [Related]
4. Arsenic Trioxide Restrains Lung Cancer Growth and Metastasis by Blocking the Calcineurin-NFAT Pathway by Upregulating DSCR1.
Yang MH; Wang YS; Shi XQ; Zhao XW; Li B
Curr Cancer Drug Targets; 2022; 22(10):854-864. PubMed ID: 35770414
[TBL] [Abstract][Full Text] [Related]
5. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer.
Yang MH; Chang KJ; Li B; Chen WS
Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499
[TBL] [Abstract][Full Text] [Related]
6. Low dosage of arsenic trioxide (As
Luo D; Zhang X; Du R; Gao W; Luo N; Zhao S; Li Y; Chen R; Wang H; Bao Y; Yang W; Liu D; Shen W
J Biol Inorg Chem; 2018 Aug; 23(6):939-947. PubMed ID: 30014256
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide: acute promyelocytic leukemia and beyond.
Bachleitner-Hofmann T; Kees M; Gisslinger H
Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer.
Ji H; Li Y; Jiang F; Wang X; Zhang J; Shen J; Yang X
Cancer Sci; 2014 Dec; 105(12):1541-9. PubMed ID: 25283513
[TBL] [Abstract][Full Text] [Related]
10. Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia.
Alimoghaddam K; Shariftabrizi A; Tavangar SM; Sanaat Z; Rostami S; Jahani M; Ghavamzadeh A
Leuk Lymphoma; 2006 Jan; 47(1):81-8. PubMed ID: 16321832
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
Huan SY; Yang CH; Chen YC
Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
[TBL] [Abstract][Full Text] [Related]
13. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
Muto A; Kizaki M; Kawamura C; Matsushita H; Fukuchi Y; Umezawa A; Yamada T; Hata J; Hozumi N; Yamato K; Ito M; Ueyama Y; Ikeda Y
Leukemia; 2001 Aug; 15(8):1176-84. PubMed ID: 11480559
[TBL] [Abstract][Full Text] [Related]
14. In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family.
Di Noto R; Boccuni P; Costantini S; Dello Russo A; Lo Pardo C; Copia C; Annunziata M; Cimino R; Ferrara F; Del Vecchio L
Tissue Antigens; 1999 Dec; 54(6):597-602. PubMed ID: 10674975
[TBL] [Abstract][Full Text] [Related]
15. Notch pathway inhibition mediated by arsenic trioxide depletes tumor initiating cells in small cell lung cancer.
Yang MH; Li B; Chang KJ
Mol Biol Rep; 2022 Mar; 49(3):2245-2253. PubMed ID: 35028858
[TBL] [Abstract][Full Text] [Related]
16. NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β-NDRG2-PP2A Complex Formation.
Park S; Han HT; Oh SS; Kim DH; Jeong JW; Lee KW; Kim M; Lim JS; Cho YY; Hwangbo C; Yoo J; Kim KD
Cells; 2019 May; 8(5):. PubMed ID: 31121982
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia drug - arsenic trioxide in the presence of eugenol shows differential action on leukemia cells (HL-60) and cardiomyocytes (H9c2) - inference from NMR study.
Binu P; Soman R; Zakhariah Hisham O; Narayanan SP; Nair RH
Toxicol Mech Methods; 2021 Jul; 31(6):457-466. PubMed ID: 33879037
[TBL] [Abstract][Full Text] [Related]
19. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice.
Liu B; Pan S; Dong X; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2006 Jul; 97(7):675-81. PubMed ID: 16827809
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide as a novel anti-glioma drug: a review.
Fang Y; Zhang Z
Cell Mol Biol Lett; 2020; 25():44. PubMed ID: 32983240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
